Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 20Breast Neoplasms 6Polycystic Ovary Syndrome 4Infertility 4Uterine Anomalies 1Sleep Wake Disorders 1Salpingitis 1Salivary Gland Neoplasms 1Primary Ovarian Insufficiency 1Pregnancy, Ectopic 1Neoplasm Metastasis 1Myofibroma 1Metabolic Syndrome 1Lymphoma 1Leiomyoma 1Infertility, Female 1Hypogonadism 1Hodgkin Disease 1Fatty Liver 1Fatigue 1Endometritis 1Endometriosis 1Bulbo-Spinal Atrophy, X-Linked 1Breast Cancer Invasive Nos 1Adenocarcinoma 1

Interventions

Glucose Tolerance Test 2penclomedine 1Triptorelin Pamoate 1Proton Magnetic Resonance Spectroscopy 1Pancreaticoduodenectomy 1Orchiectomy 1Olive Oil 1Exenatide 1Excitatory Amino Acids 1Amino Acids, Essential 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fatty Liver × Triptorelin Pamoate × Clear all
NCT02102646 2015-10-28

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

Herlev Hospital

Phase 4 Completed
31 enrolled
Genitourinary

Fatty Liver, Hypogonadism, Prostatic Neoplasms, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡